New EU data quality framework aims to align stakeholders (Cell and Gene Therapy Catapult – Regulatory Round-up – October 2022)
On the 10th of October 2022, the joint Big Data Steering Group, created by the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA), has published the Data Quality Framework for EU medicines regulation. The purpose of this framework is to put stakeholders on the same page regarding data quality.
The draft Data Quality Framework for EU medicine regulation is now open for public consultation until the 18th of November 2022.
See all of Catapult’s Regulatory Round-up for October 2022 here. Published on the 7th of November 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (25 janvier 2023). New EU data quality framework aims to align stakeholders (Cell and Gene Therapy Catapult – Regulatory Round-up – October 2022). ELSIBI. Consulté le 12 janvier 2026 à l’adresse https://doi.org/10.58079/o670





